Newcastle Innovation   Overview Newcastle Innovation is the commercial arm of The University of Newcastle. Newcastle Innovation transfers knowledge from the University to the business world and provides research services and advice to business partners. Identifying, protecting and commercialising novel technologies developed by the University’s researchers are also key areas of the business. The Newcastle Innovation business team provides a comprehensive range of services to commercial partners of the University of Newcastle. Business Opportunities (i.e Corporate Alliances/Partnerships) Newcastle Innovation is the Technology Transfer Office of the University of Newcastle, NSW Australia. Newcastle Innovation is seeking licensing partners for the listed technologies below. In addition to industry and research partners with whom we can provide research services. Our key partner targets are pharmaceutical companies of any size, biotechnology start-ups, business angel, venture capital and private equity investors. Technology/Products and Services Description Cavatak™– uses a relatively harmless human virus, Coxsackievirus A21, to attack melanoma cells. It could potentially be used against other conditions including prostate and breast cancers. Asthma vaccine – researchers at the University of Newcastle are developing a novel vaccine based on Streptococcus pneumoniae for the treatment or prevention of allergic airways diseases. Dynamin inhibitors – small molecules with the potential to treat a variety of diseases including epilepsy, cancer and infectious diseases. Visual Form Motion Test (VFM) – the VFM is a computer-based test of motion vision that is highly sensitive to subtle brain injury. The software systems will enable a clinician to diagnose a patient’s risk of vascular disease and primary stroke, as well as the potential for subsequent strokes. Inhaled vaccine for protection against bacterial infection – researchers are developing a vaccine based on extracts from bacteria or fungi which can be delivered to the lung via an inhaled vaccine to induce specific immunity and provide protection against respiratory infection or systemic infection. Probiotic P. jensenii 702 and direct fed microbials – researchers have discovered a novel probiotic strain, P. jensenii 702 which they have identified as having the potential to reduce cholesterol in humans and naturally supplement dietary vitamin B12. Mobi drip – a non-mechanical and non-electrical infusion device and offers an alternative safe and efficient intravenous infusion for the in-home care, military and veterinary markets. First aid treatment for evenomation – the invention is an innovative ointment that provides first aid treatment against snakebites such as bites from the Australian elapids or other venomous bites where pressure bandage first aid is recommended. GLAST 1B – a protein marker which is dramatically expressed by nerve cells in response to insults to the brain, such as lack of oxygen or head injury. It allows us to clearly see areas that are damaged or will be damaged. Competitive Advantages Newcastle Innovation aims to provide an efficient and effective commercial interface that focuses on: Identification, protection and commercialisation of novel technologies developed by the University's researchers. Delivery of specialist consultancy and contracted research services to industry and government. Access to the expert knowledge base that exists within the University of Newcastle. Promotion of the University of Newcastle's world-class scientific research and commercialisation activities to potential research sponsors and collaborators, licensees or investors. The professional management of these activities ensures that the economic value is fully identified, captured and distributed to the various stakeholders. Our IP portfolio and capabilities concentrate on the following areas: Biotechnology Medical devices Drug development and cancer therapeutics Reproductive sciences Bioinformatics, biomarker discovery and information base medicine Biomedical engineering Food science The University of Newcastle consistent performance in research places it in the top 10 universities in Australia for research. The University of Newcastle has some of the world's leading researchers in their field. Professor John Forbes – recently named as one of the top 10 'hottest researchers in the world' for his research into breast cancer treatment. Professor Jim Denham – coordinated two of the world’s largest trials of treatments for prostrate cancer Professor Roger Smith – involved in the discovery of the placental clock, which determines the timing of birth. Laureate Professor John Aitken – one of the world's leading researcher in the fields of human fertility, diagnosis and treatment, the development of contraceptive vaccines and in the application of reproductive technology to animal conservation. He is internationally distinguished for his work in the field of reproductive biology and in particular his work on male infertility.  Website address: www.newcastleinnovation.com.au